Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact
About Us

Valvosoft® featured in the French media

Sep 16, 2026 HeleneCardiawave 0
Scientific Publications

New publication in Circulation

Sep 3, 2026 HeleneCardiawave 0
About Us

Valvosoft® featured in France 3 Normandie

Jul 24, 2026 HeleneCardiawave 0
About Us

CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking

Jul 9, 2026 HeleneCardiawave 0
About Us

Cardiawave featured in Les Echos

Jun 23, 2026 HeleneCardiawave 0
About Us

Cardiawave joins MedTech in France

Jun 18, 2026 HeleneCardiawave 0

Blog

About Us

🚀Cardiawave featured in Biotech Finances

Feb 26, 2026
READ MORE
About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026
READ MORE
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026
READ MORE
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026
READ MORE
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026
READ MORE
Events

Cardiawave at JESFC 2026!

Jan 8, 2026
READ MORE
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025
READ MORE
Press Release

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

Dec 4, 2025
READ MORE
Events

📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025!

Nov 6, 2025
READ MORE
Press Release

Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA

Oct 30, 2025
READ MORE

Posts pagination

PrevPrevious page Page 1 Page 2 Page 3 Page 4 … Page 24 NextNext page

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Health
  • Other news
  • Press Release
  • Scientific Publications

Featured Posts

About Us

Valvosoft® featured in the French media

Sep 16, 2026 HeleneCardiawave 0
Scientific Publications

New publication in Circulation

Sep 3, 2026 HeleneCardiawave 0
About Us

Valvosoft® featured in France 3 Normandie

Jul 24, 2026 HeleneCardiawave 0
About Us

CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking

Jul 9, 2026 HeleneCardiawave 0
About Us

Cardiawave featured in Les Echos

Jun 23, 2026 HeleneCardiawave 0
About Us

Cardiawave joins MedTech in France

Jun 18, 2026 HeleneCardiawave 0

l Latest news

  • Valvosoft® featured in the French media
  • New publication in Circulation

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l February 5th 2026
  • Legal Mentions